BusinessPhoto: Mint MarketsOneSource Specialty Pharma Shares Rise 14% After Strong Q2 Results
OneSource Specialty Pharma shares surged nearly 14% following the company's Q2 report showing 37% year-on-year revenue growth and an adjusted profit after tax of ₹93.7 crore. The company reaffirmed its FY28 targets and anticipates that expanded drug-device combination capacity will drive future growth.
Mint Markets·

